OpenURL Connection Search

Select item for more details and to access through your institution.

Niacin (Vitamin B<sub>3</sub>) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor.
Published in:
Neuroendocrinology, 2016, v. 103, n. 5, p. 489, doi. 10.1159/000440621
By:
- Bouma, Grietje;
- van Faassen, Martijn;
- Kats-Ugurlu, Gursah;
- de Vries, Elisabeth G.E.;
- Kema, Ido P.;
- Walenkamp, annemiek M.E.
Publication type:
Article
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review.
Published in:
Cancers, 2020, v. 12, n. 3, p. 586, doi. 10.3390/cancers12030586
By:
- Brahm, Cyrillo G.;
- van Linde, Myra E.;
- Enting, Roelien H.;
- Schuur, Maaike;
- Otten, René H.J.;
- Heymans, Martijn W.;
- Verheul, Henk M.W.;
- Walenkamp, Annemiek M.E.
Publication type:
Article
<sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.
Published in:
Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643
By:
- Oosting, Sjoukje F.;
- van Asselt, Sophie J.;
- Brouwers, Adrienne H.;
- Bongaerts, Alfons H.H.;
- Steinberg, Julia D.J.;
- de Jong, Johan R.;
- Lub-de Hooge, Marjolijn N.;
- van der Horst-Schrivers, Anouk N.A.;
- Walenkamp, Annemiek M.E.;
- Hoving, Eelco W.;
- Sluiter, Wim J.;
- Zonnenberg, Bernard A.;
- de Vries, Elisabeth G.E.;
- Links, Thera P.
Publication type:
Article
At the Bedside: Profiling and treating patients with CXCR4‐expressing cancers.
Published in:
Journal of Leukocyte Biology, 2021, v. 109, n. 5, p. 953, doi. 10.1002/JLB.5BT1219-714R
By:
- Martin, Miguel;
- Mayer, Ingrid A.;
- Walenkamp, Annemiek M.E.;
- Lapa, Constantin;
- Andreeff, Michael;
- Bobirca, Alexandra
Publication type:
Article

Found: 4

Niacin (Vitamin B<sub>3</sub>) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor.

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review.

<sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

At the Bedside: Profiling and treating patients with CXCR4‐expressing cancers.